大型骨科手术的输血阈值:一项系统综述与Meta分析
该系统综述与Meta分析纳入9项随机试验,比较限制性与开放性输血阈值对大型骨科手术患者的影响。中等强度证据提示限制性输血策略减少输血需求(相对风险0.53,95%CI 0.39-0.71),可能降低感染但未达统计学显著(相对风险0.71,95%CI 0.47-1.06),其他临床结局无差异。
要点
- 限制性输血阈值(多比较8 vs 10 g/dL血红蛋白)减少输血需求,相对风险0.53(95%CI 0.39-0.71)。
- 限制性输血阈值可能降低总体感染,相对风险0.71(95%CI 0.47-1.06),未达统计学显著。
- 中等强度证据提示两组其他临床结局无差异。
核心结论
- 中等强度证据提示限制性输血策略减少输血利用并可能降低感染,且不增加不良结局。
研究设计与样本
- 系统综述与Meta分析,筛查504篇已发表文献,最终纳入15篇文献描述的9项随机试验。
- 大多数试验比较血红蛋白8 vs 10 g/dL的输血阈值,所有试验均涉及髋或膝关节置换术和/或髋部骨折患者。
- 采用随机效应模型进行Meta分析,用I2统计量检验异质性,用改良Jadad量表评估偏倚风险,用GRADE系统评价证据强度。
主要发现
- 中等强度证据提示限制性输血阈值组输血需求降低,相对风险0.53(95%CI 0.39-0.71;I2=95%)。
- 中等强度证据提示限制性输血阈值组平均输血单位数减少,均数差-0.95单位(95%CI -1.48至-0.41;I2=98%)。
- 限制性输血阈值组总体感染可能减少,但结果未达统计学显著,相对风险0.71(95%CI 0.47-1.06;I2=54%)。
- 中等强度证据提示两组其他临床结局无差异。
关键数值与推荐
- 限制性输血阈值组输血需求相对风险0.53(95%CI 0.39-0.71;I2=95%)。
- 限制性输血阈值组平均输血单位数均数差-0.95单位(95%CI -1.48至-0.41;I2=98%)。
- 限制性输血阈值组总体感染相对风险0.71(95%CI 0.47-1.06;I2=54%),未达统计学显著。
临床怎么用
- 中等强度证据提示限制性输血策略减少输血利用并可能降低感染,且不增加不良结局。
局限性
- 局限性包括盲法不完整、不一致性和不精确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More than a million surgeries are performed annually in the United States for hip or knee arthroplasty or hip fracture stabilization. One-fifth of these patients have blood transfusions during their hospital stay. Increases in transfusion rates have caused concern about increased adverse events from unnecessary transfusions. METHODS: We systematically reviewed randomized trials examining the effect of restrictive vs liberal transfusion thresholds on patients having major orthopedic surgery. Study results were meta-analyzed with a random-effects model and heterogeneity was tested with the I2 statistic. Study risk of bias was assessed using a modified Jadad scale and evidence strength was measured using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system. RESULTS: A total of 504 published articles were screened, and 15 met inclusion criteria. The articles described 9 randomized trials, most comparing transfusion thresholds of 8 vs 10 g/dL hemoglobin. All involved hip or knee arthroplasty and/or hip fracture patients. Moderate-strength evidence suggested a reduction in need for transfusion (relative risk, 0.53; 95% confidence interval [CI], 0.39-0.71; I2 = 95%) and mean number of units transfused (-0.95 units, 95% CI, -1.48 to -0.41, I2 = 98%). There was a possible reduction in overall infections with more restrictive transfusion thresholds, although the result was not statistically significant (relative risk, 0.71; 95% CI, 0.47-1.06; I2 = 54%). Moderate-strength evidence suggested no differences in other clinical outcomes between the groups. Limitations included incomplete blinding, inconsistency, and imprecision. CONCLUSION: Moderate-strength evidence suggests that restrictive transfusion practices reduce utilization of transfusions and may decrease infections without increasing adverse outcomes in major orthopedic surgery.
引用
- Mitchell MD, Betesh JS, Ahn J, et al. Transfusion Thresholds for Major Orthopedic Surgery: A Systematic Review and Meta-analysis. J Arthroplasty. 2017. PMID: 28735803. doi:10.1016/j.arth.2017.06.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。